2-amino-5-(2-(dimethylamino)ethyl)-8,9-dimethoxydibenzo[c,h][1,6]naphthyridin-6(5H)-one

ID: ALA5178685

PubChem CID: 10363113

Max Phase: Preclinical

Molecular Formula: C22H24N4O3

Molecular Weight: 392.46

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(=O)n(CCN(C)C)c3c4ccc(N)cc4ncc3c2cc1OC

Standard InChI:  InChI=1S/C22H24N4O3/c1-25(2)7-8-26-21-14-6-5-13(23)9-18(14)24-12-17(21)15-10-19(28-3)20(29-4)11-16(15)22(26)27/h5-6,9-12H,7-8,23H2,1-4H3

Standard InChI Key:  ZQZUTLHKODWHQW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -0.3572    0.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0717    0.4127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0717   -0.4123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3572   -0.8247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3572   -0.4123    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3572    0.4127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0717    0.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0717    1.6502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3572    2.0627    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3572    1.6502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7862    0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5007    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5008    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7863    2.0626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7863    0.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5007    0.4128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5008   -0.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7862   -0.8247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3572   -1.6496    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0716   -0.8249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0716   -1.6499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -2.0623    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -2.8874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5005   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2153   -0.8246    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9297   -0.4121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2152    0.8253    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9297    0.4129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2153    2.0623    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  7  8  2  0
 10  1  1  0
  6  7  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  7 11  1  0
 14  8  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
  2 15  1  0
 18  3  1  0
  4 19  2  0
  4  5  1  0
  5  6  1  0
  5 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
  8  9  1  0
  9 10  2  0
 17 25  1  0
 25 26  1  0
 16 27  1  0
 27 28  1  0
 13 29  1  0
M  END

Associated Targets(Human)

RPMI 8402 (281 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 392.46Molecular Weight (Monoisotopic): 392.1848AlogP: 2.86#Rotatable Bonds: 5
Polar Surface Area: 82.61Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.15CX LogP: 1.64CX LogD: 0.81
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.42Np Likeness Score: -0.65

References

1. Talukdar A, Kundu B, Sarkar D, Goon S, Mondal MA..  (2022)  Topoisomerase I inhibitors: Challenges, progress and the road ahead.,  236  [PMID:35413618] [10.1016/j.ejmech.2022.114304]

Source